Chang S. Chan

Rutgers, The State University of New Jersey — United States

Medicine · Health Sciences

23h-index4.2kcitations107works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autophagy in Disease and Therapy(27), Cancer Genomics and Diagnostics(22), Neuroendocrine Tumor Research Advances(21), DNA Repair Mechanisms(19), Lung Cancer Research Studies(19)

Publications107 total

The Somatic Aneuploidy Landscape of Adult Glia Reveals 16p as a Hotspot and Differentiates Mosaicism in Normal Glia from Chromosomal Instability in Glioblastoma
2025Open Access
Respiration defects limit serine synthesis required for lung cancer growth and survival
Nature Communications·2025· 5 citedOpen Access
Supplementary Figure 5 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 3A from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Data from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 2B from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 4 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 1B from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 5 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 3B from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 6 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Figure 3 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Figure 1 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Figure 4 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 1A from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Figure 2 from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Supplementary Table 2A from Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
2025Open Access
Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes
Cancer Research·2024· 2 citedOpen Access
Medulloblastomas Initiated by Homologous Recombination Defects in Mice
American Journal Of Pathology·2024· 1 citedOpen Access
Immune Checkpoint Blockade Delays Cancer and Extends Survival in Murine DNA Polymerase Mutator Syndromes
2024· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Eileen White(21), Shridar Ganesan(21), Saurabh V. Laddha(18), Joshua D. Rabinowitz(12), Edmund C. Lattime(11), Fuqian Shi(10), Zhixian Hu(9), Eduardo Cararo Lopes(9), Akshada Sawant(9), Hua Zhu Ke(7), Jessie Yanxiang Guo(7), Laura H. Tang(7), Christian S. Hinrichs(7), Arnold J. Levine(6), Kenneth Robzyk(6), Cen Zhang(5), Zhaohui Feng(5), Somer Abdelfattah(5), Jennele Baul(5), Jesse R. Powers(5)